Age-related macular degeneration affects the macula, the part of the retina responsible for detailed central vision. It can make reading, recognizing faces and other visual tasks difficult. Management depends on the form and stage of the disease and should be directed by an eye specialist.
A small 2010 report described improvements in visual measures after HBOT in 14 people with advanced macular degeneration. The study did not provide a controlled comparison, so it cannot establish lasting benefit or show that HBOT changes the course of the disease. HBOT remains investigational for macular degeneration and should not delay established ophthalmic treatment or monitoring.
Poor arterial blood flow can cause hard-to-heal wounds or sudden loss of retinal circulation.
A group of eye diseases that damage the optic nerve and can cause progressive, irreversible vision loss.
A retinal disease affecting central vision, making reading, faces and other detailed visual tasks harder.
Swelling in the central retina caused by fluid buildup, leading to blurred or distorted central vision.
.svg)